The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo - 16/07/18
Doi : 10.1016/j.jaad.2017.12.070
Nanja van Geel, MD, PhD a, ⁎ 
, Marcel Bekkenk, MD, PhD b, Janny E. Lommerts, MD b, Khaled Ezzedine, MD, PhD c, John Harris, MD, PhD d, Iltefat Hamzavi, MD e, Viktoria Eleftheriadou, MD, PhD f, Mauro Picardo, MD g, Alain Taieb, MD, PhD h, Cecilia A.C. Prinsen, MD, PhD i, Albert Wolkerstorfer, MD, PhD b, Reinhart Speeckaert, MD, PhD a
, Marcel Bekkenk, MD, PhD b, Janny E. Lommerts, MD b, Khaled Ezzedine, MD, PhD c, John Harris, MD, PhD d, Iltefat Hamzavi, MD e, Viktoria Eleftheriadou, MD, PhD f, Mauro Picardo, MD g, Alain Taieb, MD, PhD h, Cecilia A.C. Prinsen, MD, PhD i, Albert Wolkerstorfer, MD, PhD b, Reinhart Speeckaert, MD, PhD a a Department of Dermatology, Ghent University Hospital, Ghent, Belgium
b Department of Dermatology, University of Amsterdam and Netherlands Institute for Pigment Disorders, Amsterdam, The Netherlands
c Epidémiologie en Dermatologie et Evaluation des Thérapeutiques, Université Paris-Est, Service de Dermatologie, Hôpital Henri Mondor, Paris, France
d Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts
e Department of Dermatology, Henry Ford Hospital, Detroit, Michigan
f Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, United Kingdom
g San Gallicano Dermatology Institute, Via Elio Chianesi, Roma, Italy
h National Reference Center for Rare Skin Diseases, Hôpital St-André, University Hospital Center of Bordeaux, Bordeaux, France
i VU University Medical Center, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
∗Reprint requests: Nanja van Geel, MD, PhD, Department of Dermatology, Ghent University Hospital, Corneel Heymanslaan 10, Ghent 9000, BelgiumDepartment of DermatologyGhent University HospitalCorneel Heymanslaan 10Ghent9000Belgium
| Funding sources: Supported by the European Academy of Dermatology Venereology (project no. 2015-030) and Leo Foundation (project no. LF16092). The research activities of the principal investigator Dr van Geel are supported by the Research Foundation-Flanders (FWO Senior Clinical Investigator 1831512N). Dr Speeckaert was supported by a postdoctoral research grant (01P12914) from the Ghent University Special Research Fund. |
|
| Conflicts of interest: Drs van Geel, Speeckaert, Wolkerstorfer, Bekkenk, Lommerts, Ezzedine, and Prinsen were involved in the early development stage of the VESplus and/or VES. All authors were involved to a certain extent in the discussion around these tools during meetings. No other conflicts of interest were disclosed. |
|
| Previously presented: This work was presented at the Vitiligo International Symposium in Rome, Italy, on December 2, 2016; annual abstract session of the Global Vitiligo Foundation meeting in Orlando, Florida, on March 2, 2017; Vitiligo Global Issues Consensus Conference at the International Pigment Cell Conference in Denver, Colorado, on August 25, 2017; and Project Proposal Review Committee session during the 26th European Academy of Dermatology Venereology Congress in Geneva, Switzerland, on September 14, 2017. |
© 2018
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 79 - N° 2
P. 369-371 - août 2018 Retour au numéro
Article précédent
- Management strategies of academic pigmented lesion clinic directors in the United States
- Kelly C. Nelson, Douglas Grossman, Caroline C. Kim, Suephy C. Chen, Clara N. Curiel-Lewandrowski, James M. Grichnik, John M. Kirkwood, Sancy A. Leachman, Ashfaq A. Marghoob, Susan M. Swetter, Suraj S. Venna, Michael E. Ming
- Dermatomyositis: A diagnostic dilemma
- Diego M. Da Silva, Basil Patel, Victoria P. Werth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?